Two new reports from iData Research cover the US market for vascular access devices and the European markets for cardiac surgery and heart valve devices. The European interventional cardiology report covers markets for tissue heart ...
Tags: Medtech Markets, US market
The US Food and Drug Administration (FDA) has granted 510(k) clearance to AngioDynamics' BioFlo peripherally inserted central catheters (PICCs) with a permanent and non-eluting integral polymer Endexo technology. The BioFlo PICCs is ...
Tags: FDA, clearance, PICCs, BioFlo PICCs, PASV Valve technology
BioCardia has announced positive results from a Phase I/II trial of its Helical Infusion system, designed to deliver donor's (allogeneic) or treated patient's (autologous) adult mesenchymal stem cells (MSCs) via transendocardial stem cell ...
Tags: Helical Infusion system, stem cell injection, device, Infusion System
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Semprus BioSciences' vascular access catheter, designed to provide peripheral access to the central venous system. Using Semprus Sustain technology, the ...
Semprus BioSciences, a subsidiary of Teleflex, has received CE mark for its Nylus peripherally inserted central catheter (PICC) with Semprus Sustain technology from its notified body, the Netherlands-based DEKRA Certification Group. The ...
Tags: Nylus peripherally inserted central catheter, PICC, Nylus PICC